Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas”
1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9290541
TCL1 peptides for immunotherapy
granted -
US 9289408
High concentration baclofen preparations
granted -
US 9289131
Method and apparatus to identify vulnerable plaques with thermal wave imaging of heated nanoparticles
granted -
US 9283185
Liposomal curcumin for treatment of cancer
granted -
US 9278113
Titanium dioxide nanotubes for production and delivery of nitric oxide and methods for production thereof
granted -
US 9278068
Vesicle compositions
granted -
US 9278923
Pro-neurogenic compounds
granted -
US 9272991
Eicosanoid derivatives
granted -
US 9273288
Pseudoinfectious flavivirus and uses thereof
granted -
US 9265844
Protease degradable polypeptides and uses thereof
granted -
US 9267947
Compositions and methods for preventing or treating Burkholderia infection
granted -
US 9260510
Pertussis antibodies and uses thereof
granted -
US 9248147
Methods for endoscopic mucosal resection and endoscopic submucosal dissection
granted -
US 9250239
Compositions and methods for detecting microbial infections
granted -
US 9241998
Methods and compositions for treatment of cancer using oncolytic RSV activity
granted -
US 9243351
Fabrication of biscrolled fiber using carbon nanotube sheet
granted -
US 9243281
Neuroprotective chemicals and methods for identifying and using same
granted -
US 9243055
HERV-K antigens, antibodies, and methods
granted -
US 9241999
Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system
granted -
US 9238653
Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase
granted -
US 9233162
High affinity VEGF-receptor antagonists
granted -
US 9221800
Isoxazole treatments for diabetes
granted -
US 9216220
Compositions and methods for thermo-sensitive nanoparticles and magnetic nanoparticles
granted -
US 9216198
Compositions and medical devices for controlled release of nitric oxide and methods of production thereof
granted